World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT01089283
Date of registration: 17/03/2010
Primary sponsor: Tel-Aviv Sourasky Medical Center
Public title: Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients With Different Genetic Characteristics
Scientific title: I123 DAT-SCAN and PET-CT FDG to Assess Brain Function of Parkinson Patients With Different Genetic Characteristic
Date of first enrolment: March 2010
Target sample size: 80
Recruitment status: Not yet recruiting
URL:  http://clinicaltrials.gov/show/NCT01089283
Study type:  Observational
Study design:  Observational Model: Cohort, Time Perspective: Prospective  
Countries of recruitment
Israel
Contacts
Name:   Einat Even-Sapir, MD, PhD
Address: 
Telephone: 972-3-6974444
Email: Evensap@tasmc.health.gov.il
Affiliation: 
Name:   Einat Even-sapir, PhD, MD
Address: 
Telephone: 972-3-6974444
Email: evensap@tasmc.health.gov.il
Affiliation: 
Name:   Einat Even-Sapir, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Key inclusion & exclusion criteria

Inclusion Criteria:

- diagnosed Parkinson patients with known genetic characteristics

Exclusion Criteria:

- patients unable to understand and sign an informed consent

- minors

- patients in medical condition that does not allow them to stay still during the
examination



Age minimum: 40 Years
Age maximum: 80 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Parkinson Disease
Intervention(s)
Primary Outcome(s)
Secondary Outcome(s)
Secondary ID(s)
TASMC-10-EES-087-CTIL
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history